This systematic review and meta-analysis compared trans-carotid artery revascularization
(TCAR) as an alternative approach to carotid endarterectomy (CEA) in patients with carotid …

Objective The optimal management of patients with asymptomatic carotid stenosis (AsxCS)
is enduringly controversial. We updated our 2021 Expert Review and Position Statement …

BACKGROUND: In 2015, the FDA approved transcarotid artery revascularization (TCAR) as
an alternative to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF …

Background The effectiveness and safety of carotid artery stenting (CAS) are comparable to
those of carotid endarterectomy in both symptomatic and asymptomatic patients with carotid …

Objective We sought to quantify the percent calcification within carotid artery plaques and
assess its impact on percent residual stenosis and rate of restenosis in patients undergoing …

BACKGROUND: Transcarotid artery revascularization (TCAR) is an interventional therapy
for symptomatic internal carotid artery disease. Currently, the utilization of TCAR is …

Abstract Objective The National Coverage Determination on carotid stenting by Medicare in
October 2023 stipulates that patients participate in a shared decision-making (SDM) …

Objective Recent myocardial infarction (MI) represents a real challenge in patients requiring
any vascular procedure. There is currently a lack of data on the effect of preoperative MI on …

Introduction Carotid artery angioplasty and stenting (CAS) is an established procedure to
treat carotid artery stenosis for either primary or secondary prevention of stroke …

Carotid artery stenosis remains one of the most commonly treated diagnoses by vascular
specialists in the United States. The optimal management of carotid stenosis remains …